Valuation: Emergent BioSolutions Inc.

Market Cap 235M 203M 191M 174M 326M 22.46B 332M 2.24B 876M 11.26B 883M 864M 37.5B P/E 2026 *
-0.99x
P/E 2027 * 16.4x
Enterprise Value 235M 203M 191M 174M 326M 22.46B 332M 2.24B 876M 11.26B 883M 864M 37.5B EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.29x
Free-Float
43.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.23%
1 week-5.17%
Current month-36.43%
1 month-41.83%
3 months-42.19%
6 months-57.62%
Current year-62.86%
1 week 4.36
Extreme 4.36
4.73
1 month 4.36
Extreme 4.36
7.73
Current year 4.36
Extreme 4.36
14.06
1 year 4.36
Extreme 4.36
14.06
3 years 1.42
Extreme 1.42
15.1
5 years 1.42
Extreme 1.42
65.09
10 years 1.42
Extreme 1.42
137.61
Manager TitleAgeSince
Chief Executive Officer 70 2024-02-20
Director of Finance/CFO 62 2018-03-25
Chief Tech/Sci/R&D Officer 53 2024-11-17
Director TitleAgeSince
Chairman 82 2022-03-31
Director/Board Member 70 2004-12-31
Director/Board Member 77 2016-09-30
Date Insider Type Main position Quantity % Market Cap.
8/5/26 Other

Executive/Senior Manager

455,311 0.8824%
7/1/26 Sell

Executive/Senior Manager

-3,000 0.0058%
4/29/26 Free

Executive/Senior Manager

100,111 0.1934%
Change 5-day change 1-year change 3-year change Capi.($)
+2.23%-5.17%-48.08%-11.56% 235M
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -0.80%-1.15%+19.63%+37.25% 359.54B
Weighted average by Cap. -1.36%+0.31%+39.08%+61.28%

Financials

2026 *2027 *
Net sales 656M 567M 533M 485M 910M 62.56B 926M 6.24B 2.44B 31.36B 2.46B 2.41B 104B 810M 700M 659M 599M 1.12B 77.29B 1.14B 7.71B 3.01B 38.74B 3.04B 2.97B 129B
Net income -241M -209M -196M -178M -335M -23.03B -341M -2.3B -898M -11.54B -906M -887M -38.46B 14.5M 12.54M 11.79M 10.72M 20.12M 1.38B 20.47M 138M 53.94M 693M 54.42M 53.26M 2.31B
Net Debt - -
Logo Emergent BioSolutions Inc.
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Employees
900
Date Price Change Volume
26-08-14 US$4.590 +2.23% 1,095,416
26-08-13 US$4.490 -1.32% 1,461,108
26-08-12 US$4.550 +2.25% 1,698,371
26-08-11 US$4.450 -0.45% 1,755,488
26-08-10 US$4.470 -7.64% 4,332,817
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.590USD
Average target price
11.00USD
Spread / Average Target
+139.65%

Quarterly revenue - Rate of surprise